Parexel hires clinical research execs; Europe moves toward trial transparency;

> Parexel ($PRXL) has appointed two vice presidents in its clinical research business, tasking Accenture veteran Roland Andersson with overseeing its Phase II-III unit and putting former UCB exec Thomas Senderovitz in charge of the early-phase and clinical logistics segments. More

> Europe is planning to create a publicly accessible database of clinical trial results. News

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.